The recent GameStop-driven market surge has subsided, but Injective (INJ) is showing signs of resilience. Despite the broader altcoin market retreating, INJ is bucking the trend, posting gains on its daily price chart. This unexpected strength can be attributed to the unwavering support of long-term Injective investors, who are refraining from selling and thereby reducing downside pressure.

After experiencing a significant decline to yearly lows, Injective is now exhibiting a notable recovery. Encouraging indicators include a decrease in INJ tokens being sent to exchanges, signifying a reduced desire to sell. Additionally, the Average Coin Age metric, which measures how long holders keep digital assets in their wallets, is soaring, indicating a shift towards accumulation rather than selling.

Injective's price has rebounded from $21.3 to $23.26, representing a 0.18% increase over the past 24 hours. With long-term holders continuing to support the token, INJ appears poised to extend its upside. The next target could be the $28 value area, but broader market developments, particularly Bitcoin's performance, will play a crucial role in shaping INJ's price trajectory.

Injective's ability to withstand the current market downturn is a testament to the loyalty and conviction of its investor base. As the cryptocurrency landscape continues to evolve, INJ's resilience could be a harbinger of future growth and success. With its supportive community and encouraging indicators, Injective is well-positioned to navigate the challenges ahead and potentially emerge as a leader in the altcoin market.